Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-02

FDA Approved: TIMOLOL MALEATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings' original ANDA for timolol maleate, a generic ophthalmic beta-blocker intended to reduce intraocular pressure in glaucoma an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol maleate (Timolol maleate)

Snippet

ORIG AP for TIMOLOL MALEATE (TIMOLOL MALEATE)